Navigation Links
VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer

VENTURA, Calif., Dec. 12 /PRNewswire/ -- VivoMetrics Inc., a provider of leading edge non-invasive vital function monitoring, announced the appointment of Howard R. Baker to the position of president and chief executive officer. Mr. Baker succeeds Paul Kennedy, who will remain with the company in the role of executive vice president.

Mr. Baker joins VivoMetrics with over 28 years in leadership roles: developing global markets, commercializing products and services and helping pioneer adoption of innovative technologies. Prior to joining VivoMetrics, Mr. Baker served 10 years in senior management positions at Medtronic Corporation, the Fortune 500 global leader in medical device technologies, within the emergency response systems, cardiac surgery and diabetes businesses. Over the previous 11 years, he served in executive and senior leadership positions at Positron Corporation, a pioneer in positron emission tomography (PET) imaging technologies, and Fonar Corporation, an innovator and supplier of magnetic resonance imaging devices and services. Mr. Baker began his career in sales at leading health care companies including Space Labs, CR Bard and Abbott Labs.

"We are pleased to have someone with Howard's extensive background and proven track record take over the helm at VivoMetrics," commented John Erb, chairman of the VivoMetrics board of directors. Mr. Erb continued by saying, "Howard's leadership experience, along with demonstrated successes in developing and expanding market opportunities for technology, products and services, make him well-qualified to lead VivoMetrics towards its anticipated accelerated growth."

"VivoMetrics stands poised to take advantage of market development opportunities that have been cultivated over the past eight years, and I'm very excited to join the company at this time," said Mr. Baker. "VivoMetrics has developed technology and led the charge in changing how scientific research, clinical study and fitness assessment are conducted. I think the potential for our future success is unlimited."

About VivoMetrics

VivoMetrics, founded in 1999 and based in Ventura, Calif., provides non-invasive products and services, using its proprietary LifeShirt(R) technology, which continuously monitor vital, life-sign functions, such as heart rate, ECG, respiration rate, flow, and volume, posture, and activity. The company's offerings, based on patented, field-tested technologies, were initially focused on improving the speed, outcomes and economics of pharmaceutical research. Since its inception, the company has further expanded its offerings for use by military, first responder and biohazard personnel, as well as athletes and for clinical, academic and corporate research.

SOURCE VivoMetrics
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
2. Codexis Appoints Singapore Laboratories Managing Director
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
6. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
7. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
8. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
9. NeurogesX Appoints New Director to the Board
10. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
11. Premier Research Appoints Melissa Jones as Vice President, International Business Development
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/12/2016)... , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
Breaking Biology News(10 mins):